Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Stock
Stocks
2315
CNE100005D27
Biotechnology & Medical Research
|
End-of-day quote
Hong Kong S.E.
30/10/2026
|
5-day change | 1st Jan Change | ||
| 38.30 CNY | -8.81% |
|
-7.08% | +8.50% |
| 10-29 | Biocytogen Pharmaceuticals Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026 | CI |
| 10-29 | Biocytogen Pharmaceuticals Posts Higher Q3 Attributable Profit; Revenue Up | MT |
| Market Cap | 29.6B 4.45B 3.98B 3.66B 3.32B 6.2B 422B 6.32B 43.69B 17.54B 222B 16.69B 16.33B 700B | P/E 2026 * |
37.8x | P/E 2027 * | 24x |
|---|---|---|---|---|---|
| Enterprise Value | 29.6B 4.45B 3.98B 3.66B 3.32B 6.2B 422B 6.32B 43.69B 17.54B 222B 16.69B 16.33B 700B | EV / Sales 2026 * |
15.2x | EV / Sales 2027 * | 11.2x |
| Free-Float |
66.45% | Yield 2026 * |
-
| Yield 2027 * | - |
Hong Kong S.E.CNY
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2315 | End-of-day quote | |
Hong Kong S.E.
| 2315 | Delayed | |
|
Deutsche Boerse AG
| I54 | Delayed | |
|
Boerse Muenchen
| I54 | Real-time |
| 1 day | -8.81% | ||
| 1 week | -7.08% | ||
| Current month | -45.29% | ||
| 1 month | -40.80% | ||
| 3 months | -27.19% | ||
| 6 months | -23.71% | ||
| Current year | +8.50% |
| 1 week | 36.26 |  | 44.74 |
| 1 month | 36.26 | | 80.65 |
| Current year | 33.14 | | 80.65 |
| 1 year | 24.8 | | 80.65 |
| 3 years | 5.6 | | 80.65 |
| 5 years | 5.6 | | 80.65 |
| 10 years | 5.6 | | 80.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yue Lei Shen
CEO | Chief Executive Officer | 57 | 13/11/2009 |
Liu Bin
DFI | Director of Finance/CFO | 58 | 05/01/2020 |
Sabrina Wang
COO | Chief Operating Officer | 47 | 01/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Yue Lei Shen
CHM | Chairman | 57 | 22/01/2013 |
Ke Xiang Zhou
BRD | Director/Board Member | 62 | 12/03/2018 |
Jian Ni
CHM | Chairman | 55 | 13/11/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.81% | -7.08% | +53.57% | +224.58% | 4.76B | |
| -0.62% | +0.50% | +33.92% | +60.07% | 64.38B | |
| +0.35% | +3.04% | +12.64% | +83.62% | 56.16B | |
| +0.53% | +2.55% | +13.90% | +104.77% | 54.16B | |
| -2.81% | -4.31% | +23.50% | +50.90% | 45.33B | |
| -0.33% | -1.93% | +20.15% | +98.45% | 42.25B | |
| +0.55% | +2.31% | +224.97% | +942.56% | 40.78B | |
| +3.27% | +47.40% | +110.44% | +94.92% | 33.8B | |
| +1.22% | -1.39% | +13.92% | +46.95% | 32.25B | |
| -1.29% | -1.72% | +21.00% | -6.85% | 23.57B | |
| Average | -0.80% | +3.83% | +52.80% | +170.00% | 39.74B | |
| Weighted average by Cap. | -0.10% | +3.55% | +49.49% | +162.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.94B 292M 262M 241M 218M 408M 27.73B 415M 2.87B 1.15B 14.59B 1.1B 1.07B 46.01B | 2.64B 396M 355M 327M 296M 553M 37.63B 563M 3.89B 1.56B 19.8B 1.49B 1.46B 62.43B |
| Net income | 384M 57.69M 51.67M 47.53M 43.07M 80.5M 5.48B 82.01M 567M 228M 2.88B 217M 212M 9.09B | 605M 90.9M 81.41M 74.88M 67.85M 127M 8.63B 129M 893M 358M 4.54B 341M 334M 14.32B |
| Net Debt | - | - |
Employees
1,922
Calendar
12:00pm
Earnings release - Q3 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | CN¥38.30 | -8.81% | 4,019,000 |
| 29/10/26 | CN¥42.00 | -2.19% | 1,603,000 |
| 28/10/26 | CN¥42.94 | +7.24% | 2,476,000 |
| 27/10/26 | CN¥40.04 | +0.15% | 2,416,789 |
| 26/10/26 | CN¥39.98 | -3.66% | 1,583,000 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
32.49CNY
Average target price
53.66CNY
Spread / Average Target
+65.13%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 2315 Stock
Select your edition
All financial news and data tailored to specific country editions
